We've found
427
archived clinical trials in
Shingles
We've found
427
archived clinical trials in
Shingles
Study to Evaluate Efficacy, Safety, and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster Vaccine GSK1437173A
Updated: 12/20/2017
Observer-blind Study to Evaluate Efficacy, Safety, and Immunogenicity of GSK Biologicals' Herpes Zoster Vaccine GSK1437173A
Status: Enrolling
Updated: 12/20/2017
Study to Evaluate Efficacy, Safety, and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster Vaccine GSK1437173A
Updated: 12/20/2017
Observer-blind Study to Evaluate Efficacy, Safety, and Immunogenicity of GSK Biologicals' Herpes Zoster Vaccine GSK1437173A
Status: Enrolling
Updated: 12/20/2017
Click here to add this to my saved trials
Study to Evaluate Efficacy, Safety, and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster Vaccine GSK1437173A
Updated: 12/20/2017
Observer-blind Study to Evaluate Efficacy, Safety, and Immunogenicity of GSK Biologicals' Herpes Zoster Vaccine GSK1437173A
Status: Enrolling
Updated: 12/20/2017
Study to Evaluate Efficacy, Safety, and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster Vaccine GSK1437173A
Updated: 12/20/2017
Observer-blind Study to Evaluate Efficacy, Safety, and Immunogenicity of GSK Biologicals' Herpes Zoster Vaccine GSK1437173A
Status: Enrolling
Updated: 12/20/2017
Click here to add this to my saved trials
Study to Evaluate Efficacy, Safety, and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster Vaccine GSK1437173A
Updated: 12/20/2017
Observer-blind Study to Evaluate Efficacy, Safety, and Immunogenicity of GSK Biologicals' Herpes Zoster Vaccine GSK1437173A
Status: Enrolling
Updated: 12/20/2017
Study to Evaluate Efficacy, Safety, and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster Vaccine GSK1437173A
Updated: 12/20/2017
Observer-blind Study to Evaluate Efficacy, Safety, and Immunogenicity of GSK Biologicals' Herpes Zoster Vaccine GSK1437173A
Status: Enrolling
Updated: 12/20/2017
Click here to add this to my saved trials
Study to Evaluate Efficacy, Safety, and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster Vaccine GSK1437173A
Updated: 12/20/2017
Observer-blind Study to Evaluate Efficacy, Safety, and Immunogenicity of GSK Biologicals' Herpes Zoster Vaccine GSK1437173A
Status: Enrolling
Updated: 12/20/2017
Study to Evaluate Efficacy, Safety, and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster Vaccine GSK1437173A
Updated: 12/20/2017
Observer-blind Study to Evaluate Efficacy, Safety, and Immunogenicity of GSK Biologicals' Herpes Zoster Vaccine GSK1437173A
Status: Enrolling
Updated: 12/20/2017
Click here to add this to my saved trials
A Comparative Study of FV-100 vs. Valacyclovir for the Prevention of Post-Herpetic Neuralgia
Updated: 12/20/2017
A Multicenter, Randomized, Double-Blind, Parallel-Group, Comparative Study of FV-100 vs. Valacyclovir for the Prevention of Post-Herpetic Neuralgia and Treatment of Acute Herpes Zoster Associated Pain
Status: Enrolling
Updated: 12/20/2017
A Comparative Study of FV-100 vs. Valacyclovir for the Prevention of Post-Herpetic Neuralgia
Updated: 12/20/2017
A Multicenter, Randomized, Double-Blind, Parallel-Group, Comparative Study of FV-100 vs. Valacyclovir for the Prevention of Post-Herpetic Neuralgia and Treatment of Acute Herpes Zoster Associated Pain
Status: Enrolling
Updated: 12/20/2017
Click here to add this to my saved trials
Live Zoster Vaccine in HIV-Infected Adults on Antiretroviral Therapy
Updated: 1/8/2018
A Phase II, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Evaluate the Safety, Tolerability, and Immunogenicity of ZOSTAVAX® (Zoster Vaccine Live) in Human Immunodeficiency Virus (HIV)-1-Infected Adults on Potent Combination ART With Conserved Immune Function
Status: Enrolling
Updated: 1/8/2018
Live Zoster Vaccine in HIV-Infected Adults on Antiretroviral Therapy
Updated: 1/8/2018
A Phase II, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Evaluate the Safety, Tolerability, and Immunogenicity of ZOSTAVAX® (Zoster Vaccine Live) in Human Immunodeficiency Virus (HIV)-1-Infected Adults on Potent Combination ART With Conserved Immune Function
Status: Enrolling
Updated: 1/8/2018
Click here to add this to my saved trials
Live Zoster Vaccine in HIV-Infected Adults on Antiretroviral Therapy
Updated: 1/8/2018
A Phase II, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Evaluate the Safety, Tolerability, and Immunogenicity of ZOSTAVAX® (Zoster Vaccine Live) in Human Immunodeficiency Virus (HIV)-1-Infected Adults on Potent Combination ART With Conserved Immune Function
Status: Enrolling
Updated: 1/8/2018
Live Zoster Vaccine in HIV-Infected Adults on Antiretroviral Therapy
Updated: 1/8/2018
A Phase II, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Evaluate the Safety, Tolerability, and Immunogenicity of ZOSTAVAX® (Zoster Vaccine Live) in Human Immunodeficiency Virus (HIV)-1-Infected Adults on Potent Combination ART With Conserved Immune Function
Status: Enrolling
Updated: 1/8/2018
Click here to add this to my saved trials
Live Zoster Vaccine in HIV-Infected Adults on Antiretroviral Therapy
Updated: 1/8/2018
A Phase II, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Evaluate the Safety, Tolerability, and Immunogenicity of ZOSTAVAX® (Zoster Vaccine Live) in Human Immunodeficiency Virus (HIV)-1-Infected Adults on Potent Combination ART With Conserved Immune Function
Status: Enrolling
Updated: 1/8/2018
Live Zoster Vaccine in HIV-Infected Adults on Antiretroviral Therapy
Updated: 1/8/2018
A Phase II, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Evaluate the Safety, Tolerability, and Immunogenicity of ZOSTAVAX® (Zoster Vaccine Live) in Human Immunodeficiency Virus (HIV)-1-Infected Adults on Potent Combination ART With Conserved Immune Function
Status: Enrolling
Updated: 1/8/2018
Click here to add this to my saved trials
Live Zoster Vaccine in HIV-Infected Adults on Antiretroviral Therapy
Updated: 1/8/2018
A Phase II, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Evaluate the Safety, Tolerability, and Immunogenicity of ZOSTAVAX® (Zoster Vaccine Live) in Human Immunodeficiency Virus (HIV)-1-Infected Adults on Potent Combination ART With Conserved Immune Function
Status: Enrolling
Updated: 1/8/2018
Live Zoster Vaccine in HIV-Infected Adults on Antiretroviral Therapy
Updated: 1/8/2018
A Phase II, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Evaluate the Safety, Tolerability, and Immunogenicity of ZOSTAVAX® (Zoster Vaccine Live) in Human Immunodeficiency Virus (HIV)-1-Infected Adults on Potent Combination ART With Conserved Immune Function
Status: Enrolling
Updated: 1/8/2018
Click here to add this to my saved trials
Live Zoster Vaccine in HIV-Infected Adults on Antiretroviral Therapy
Updated: 1/8/2018
A Phase II, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Evaluate the Safety, Tolerability, and Immunogenicity of ZOSTAVAX® (Zoster Vaccine Live) in Human Immunodeficiency Virus (HIV)-1-Infected Adults on Potent Combination ART With Conserved Immune Function
Status: Enrolling
Updated: 1/8/2018
Live Zoster Vaccine in HIV-Infected Adults on Antiretroviral Therapy
Updated: 1/8/2018
A Phase II, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Evaluate the Safety, Tolerability, and Immunogenicity of ZOSTAVAX® (Zoster Vaccine Live) in Human Immunodeficiency Virus (HIV)-1-Infected Adults on Potent Combination ART With Conserved Immune Function
Status: Enrolling
Updated: 1/8/2018
Click here to add this to my saved trials
Live Zoster Vaccine in HIV-Infected Adults on Antiretroviral Therapy
Updated: 1/8/2018
A Phase II, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Evaluate the Safety, Tolerability, and Immunogenicity of ZOSTAVAX® (Zoster Vaccine Live) in Human Immunodeficiency Virus (HIV)-1-Infected Adults on Potent Combination ART With Conserved Immune Function
Status: Enrolling
Updated: 1/8/2018
Live Zoster Vaccine in HIV-Infected Adults on Antiretroviral Therapy
Updated: 1/8/2018
A Phase II, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Evaluate the Safety, Tolerability, and Immunogenicity of ZOSTAVAX® (Zoster Vaccine Live) in Human Immunodeficiency Virus (HIV)-1-Infected Adults on Potent Combination ART With Conserved Immune Function
Status: Enrolling
Updated: 1/8/2018
Click here to add this to my saved trials
Live Zoster Vaccine in HIV-Infected Adults on Antiretroviral Therapy
Updated: 1/8/2018
A Phase II, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Evaluate the Safety, Tolerability, and Immunogenicity of ZOSTAVAX® (Zoster Vaccine Live) in Human Immunodeficiency Virus (HIV)-1-Infected Adults on Potent Combination ART With Conserved Immune Function
Status: Enrolling
Updated: 1/8/2018
Live Zoster Vaccine in HIV-Infected Adults on Antiretroviral Therapy
Updated: 1/8/2018
A Phase II, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Evaluate the Safety, Tolerability, and Immunogenicity of ZOSTAVAX® (Zoster Vaccine Live) in Human Immunodeficiency Virus (HIV)-1-Infected Adults on Potent Combination ART With Conserved Immune Function
Status: Enrolling
Updated: 1/8/2018
Click here to add this to my saved trials
Live Zoster Vaccine in HIV-Infected Adults on Antiretroviral Therapy
Updated: 1/8/2018
A Phase II, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Evaluate the Safety, Tolerability, and Immunogenicity of ZOSTAVAX® (Zoster Vaccine Live) in Human Immunodeficiency Virus (HIV)-1-Infected Adults on Potent Combination ART With Conserved Immune Function
Status: Enrolling
Updated: 1/8/2018
Live Zoster Vaccine in HIV-Infected Adults on Antiretroviral Therapy
Updated: 1/8/2018
A Phase II, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Evaluate the Safety, Tolerability, and Immunogenicity of ZOSTAVAX® (Zoster Vaccine Live) in Human Immunodeficiency Virus (HIV)-1-Infected Adults on Potent Combination ART With Conserved Immune Function
Status: Enrolling
Updated: 1/8/2018
Click here to add this to my saved trials
Live Zoster Vaccine in HIV-Infected Adults on Antiretroviral Therapy
Updated: 1/8/2018
A Phase II, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Evaluate the Safety, Tolerability, and Immunogenicity of ZOSTAVAX® (Zoster Vaccine Live) in Human Immunodeficiency Virus (HIV)-1-Infected Adults on Potent Combination ART With Conserved Immune Function
Status: Enrolling
Updated: 1/8/2018
Live Zoster Vaccine in HIV-Infected Adults on Antiretroviral Therapy
Updated: 1/8/2018
A Phase II, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Evaluate the Safety, Tolerability, and Immunogenicity of ZOSTAVAX® (Zoster Vaccine Live) in Human Immunodeficiency Virus (HIV)-1-Infected Adults on Potent Combination ART With Conserved Immune Function
Status: Enrolling
Updated: 1/8/2018
Click here to add this to my saved trials
Live Zoster Vaccine in HIV-Infected Adults on Antiretroviral Therapy
Updated: 1/8/2018
A Phase II, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Evaluate the Safety, Tolerability, and Immunogenicity of ZOSTAVAX® (Zoster Vaccine Live) in Human Immunodeficiency Virus (HIV)-1-Infected Adults on Potent Combination ART With Conserved Immune Function
Status: Enrolling
Updated: 1/8/2018
Live Zoster Vaccine in HIV-Infected Adults on Antiretroviral Therapy
Updated: 1/8/2018
A Phase II, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Evaluate the Safety, Tolerability, and Immunogenicity of ZOSTAVAX® (Zoster Vaccine Live) in Human Immunodeficiency Virus (HIV)-1-Infected Adults on Potent Combination ART With Conserved Immune Function
Status: Enrolling
Updated: 1/8/2018
Click here to add this to my saved trials
Live Zoster Vaccine in HIV-Infected Adults on Antiretroviral Therapy
Updated: 1/8/2018
A Phase II, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Evaluate the Safety, Tolerability, and Immunogenicity of ZOSTAVAX® (Zoster Vaccine Live) in Human Immunodeficiency Virus (HIV)-1-Infected Adults on Potent Combination ART With Conserved Immune Function
Status: Enrolling
Updated: 1/8/2018
Live Zoster Vaccine in HIV-Infected Adults on Antiretroviral Therapy
Updated: 1/8/2018
A Phase II, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Evaluate the Safety, Tolerability, and Immunogenicity of ZOSTAVAX® (Zoster Vaccine Live) in Human Immunodeficiency Virus (HIV)-1-Infected Adults on Potent Combination ART With Conserved Immune Function
Status: Enrolling
Updated: 1/8/2018
Click here to add this to my saved trials
Live Zoster Vaccine in HIV-Infected Adults on Antiretroviral Therapy
Updated: 1/8/2018
A Phase II, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Evaluate the Safety, Tolerability, and Immunogenicity of ZOSTAVAX® (Zoster Vaccine Live) in Human Immunodeficiency Virus (HIV)-1-Infected Adults on Potent Combination ART With Conserved Immune Function
Status: Enrolling
Updated: 1/8/2018
Live Zoster Vaccine in HIV-Infected Adults on Antiretroviral Therapy
Updated: 1/8/2018
A Phase II, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Evaluate the Safety, Tolerability, and Immunogenicity of ZOSTAVAX® (Zoster Vaccine Live) in Human Immunodeficiency Virus (HIV)-1-Infected Adults on Potent Combination ART With Conserved Immune Function
Status: Enrolling
Updated: 1/8/2018
Click here to add this to my saved trials
Live Zoster Vaccine in HIV-Infected Adults on Antiretroviral Therapy
Updated: 1/8/2018
A Phase II, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Evaluate the Safety, Tolerability, and Immunogenicity of ZOSTAVAX® (Zoster Vaccine Live) in Human Immunodeficiency Virus (HIV)-1-Infected Adults on Potent Combination ART With Conserved Immune Function
Status: Enrolling
Updated: 1/8/2018
Live Zoster Vaccine in HIV-Infected Adults on Antiretroviral Therapy
Updated: 1/8/2018
A Phase II, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Evaluate the Safety, Tolerability, and Immunogenicity of ZOSTAVAX® (Zoster Vaccine Live) in Human Immunodeficiency Virus (HIV)-1-Infected Adults on Potent Combination ART With Conserved Immune Function
Status: Enrolling
Updated: 1/8/2018
Click here to add this to my saved trials
Live Zoster Vaccine in HIV-Infected Adults on Antiretroviral Therapy
Updated: 1/8/2018
A Phase II, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Evaluate the Safety, Tolerability, and Immunogenicity of ZOSTAVAX® (Zoster Vaccine Live) in Human Immunodeficiency Virus (HIV)-1-Infected Adults on Potent Combination ART With Conserved Immune Function
Status: Enrolling
Updated: 1/8/2018
Live Zoster Vaccine in HIV-Infected Adults on Antiretroviral Therapy
Updated: 1/8/2018
A Phase II, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Evaluate the Safety, Tolerability, and Immunogenicity of ZOSTAVAX® (Zoster Vaccine Live) in Human Immunodeficiency Virus (HIV)-1-Infected Adults on Potent Combination ART With Conserved Immune Function
Status: Enrolling
Updated: 1/8/2018
Click here to add this to my saved trials
Live Zoster Vaccine in HIV-Infected Adults on Antiretroviral Therapy
Updated: 1/8/2018
A Phase II, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Evaluate the Safety, Tolerability, and Immunogenicity of ZOSTAVAX® (Zoster Vaccine Live) in Human Immunodeficiency Virus (HIV)-1-Infected Adults on Potent Combination ART With Conserved Immune Function
Status: Enrolling
Updated: 1/8/2018
Live Zoster Vaccine in HIV-Infected Adults on Antiretroviral Therapy
Updated: 1/8/2018
A Phase II, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Evaluate the Safety, Tolerability, and Immunogenicity of ZOSTAVAX® (Zoster Vaccine Live) in Human Immunodeficiency Virus (HIV)-1-Infected Adults on Potent Combination ART With Conserved Immune Function
Status: Enrolling
Updated: 1/8/2018
Click here to add this to my saved trials
Live Zoster Vaccine in HIV-Infected Adults on Antiretroviral Therapy
Updated: 1/8/2018
A Phase II, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Evaluate the Safety, Tolerability, and Immunogenicity of ZOSTAVAX® (Zoster Vaccine Live) in Human Immunodeficiency Virus (HIV)-1-Infected Adults on Potent Combination ART With Conserved Immune Function
Status: Enrolling
Updated: 1/8/2018
Live Zoster Vaccine in HIV-Infected Adults on Antiretroviral Therapy
Updated: 1/8/2018
A Phase II, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Evaluate the Safety, Tolerability, and Immunogenicity of ZOSTAVAX® (Zoster Vaccine Live) in Human Immunodeficiency Virus (HIV)-1-Infected Adults on Potent Combination ART With Conserved Immune Function
Status: Enrolling
Updated: 1/8/2018
Click here to add this to my saved trials
Live Zoster Vaccine in HIV-Infected Adults on Antiretroviral Therapy
Updated: 1/8/2018
A Phase II, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Evaluate the Safety, Tolerability, and Immunogenicity of ZOSTAVAX® (Zoster Vaccine Live) in Human Immunodeficiency Virus (HIV)-1-Infected Adults on Potent Combination ART With Conserved Immune Function
Status: Enrolling
Updated: 1/8/2018
Live Zoster Vaccine in HIV-Infected Adults on Antiretroviral Therapy
Updated: 1/8/2018
A Phase II, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Evaluate the Safety, Tolerability, and Immunogenicity of ZOSTAVAX® (Zoster Vaccine Live) in Human Immunodeficiency Virus (HIV)-1-Infected Adults on Potent Combination ART With Conserved Immune Function
Status: Enrolling
Updated: 1/8/2018
Click here to add this to my saved trials
Live Zoster Vaccine in HIV-Infected Adults on Antiretroviral Therapy
Updated: 1/8/2018
A Phase II, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Evaluate the Safety, Tolerability, and Immunogenicity of ZOSTAVAX® (Zoster Vaccine Live) in Human Immunodeficiency Virus (HIV)-1-Infected Adults on Potent Combination ART With Conserved Immune Function
Status: Enrolling
Updated: 1/8/2018
Live Zoster Vaccine in HIV-Infected Adults on Antiretroviral Therapy
Updated: 1/8/2018
A Phase II, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Evaluate the Safety, Tolerability, and Immunogenicity of ZOSTAVAX® (Zoster Vaccine Live) in Human Immunodeficiency Virus (HIV)-1-Infected Adults on Potent Combination ART With Conserved Immune Function
Status: Enrolling
Updated: 1/8/2018
Click here to add this to my saved trials
Live Zoster Vaccine in HIV-Infected Adults on Antiretroviral Therapy
Updated: 1/8/2018
A Phase II, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Evaluate the Safety, Tolerability, and Immunogenicity of ZOSTAVAX® (Zoster Vaccine Live) in Human Immunodeficiency Virus (HIV)-1-Infected Adults on Potent Combination ART With Conserved Immune Function
Status: Enrolling
Updated: 1/8/2018
Live Zoster Vaccine in HIV-Infected Adults on Antiretroviral Therapy
Updated: 1/8/2018
A Phase II, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Evaluate the Safety, Tolerability, and Immunogenicity of ZOSTAVAX® (Zoster Vaccine Live) in Human Immunodeficiency Virus (HIV)-1-Infected Adults on Potent Combination ART With Conserved Immune Function
Status: Enrolling
Updated: 1/8/2018
Click here to add this to my saved trials
Live Zoster Vaccine in HIV-Infected Adults on Antiretroviral Therapy
Updated: 1/8/2018
A Phase II, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Evaluate the Safety, Tolerability, and Immunogenicity of ZOSTAVAX® (Zoster Vaccine Live) in Human Immunodeficiency Virus (HIV)-1-Infected Adults on Potent Combination ART With Conserved Immune Function
Status: Enrolling
Updated: 1/8/2018
Live Zoster Vaccine in HIV-Infected Adults on Antiretroviral Therapy
Updated: 1/8/2018
A Phase II, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Evaluate the Safety, Tolerability, and Immunogenicity of ZOSTAVAX® (Zoster Vaccine Live) in Human Immunodeficiency Virus (HIV)-1-Infected Adults on Potent Combination ART With Conserved Immune Function
Status: Enrolling
Updated: 1/8/2018
Click here to add this to my saved trials
Live Zoster Vaccine in HIV-Infected Adults on Antiretroviral Therapy
Updated: 1/8/2018
A Phase II, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Evaluate the Safety, Tolerability, and Immunogenicity of ZOSTAVAX® (Zoster Vaccine Live) in Human Immunodeficiency Virus (HIV)-1-Infected Adults on Potent Combination ART With Conserved Immune Function
Status: Enrolling
Updated: 1/8/2018
Live Zoster Vaccine in HIV-Infected Adults on Antiretroviral Therapy
Updated: 1/8/2018
A Phase II, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Evaluate the Safety, Tolerability, and Immunogenicity of ZOSTAVAX® (Zoster Vaccine Live) in Human Immunodeficiency Virus (HIV)-1-Infected Adults on Potent Combination ART With Conserved Immune Function
Status: Enrolling
Updated: 1/8/2018
Click here to add this to my saved trials
Live Zoster Vaccine in HIV-Infected Adults on Antiretroviral Therapy
Updated: 1/8/2018
A Phase II, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Evaluate the Safety, Tolerability, and Immunogenicity of ZOSTAVAX® (Zoster Vaccine Live) in Human Immunodeficiency Virus (HIV)-1-Infected Adults on Potent Combination ART With Conserved Immune Function
Status: Enrolling
Updated: 1/8/2018
Live Zoster Vaccine in HIV-Infected Adults on Antiretroviral Therapy
Updated: 1/8/2018
A Phase II, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Evaluate the Safety, Tolerability, and Immunogenicity of ZOSTAVAX® (Zoster Vaccine Live) in Human Immunodeficiency Virus (HIV)-1-Infected Adults on Potent Combination ART With Conserved Immune Function
Status: Enrolling
Updated: 1/8/2018
Click here to add this to my saved trials
Live Zoster Vaccine in HIV-Infected Adults on Antiretroviral Therapy
Updated: 1/8/2018
A Phase II, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Evaluate the Safety, Tolerability, and Immunogenicity of ZOSTAVAX® (Zoster Vaccine Live) in Human Immunodeficiency Virus (HIV)-1-Infected Adults on Potent Combination ART With Conserved Immune Function
Status: Enrolling
Updated: 1/8/2018
Live Zoster Vaccine in HIV-Infected Adults on Antiretroviral Therapy
Updated: 1/8/2018
A Phase II, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Evaluate the Safety, Tolerability, and Immunogenicity of ZOSTAVAX® (Zoster Vaccine Live) in Human Immunodeficiency Virus (HIV)-1-Infected Adults on Potent Combination ART With Conserved Immune Function
Status: Enrolling
Updated: 1/8/2018
Click here to add this to my saved trials
Live Zoster Vaccine in HIV-Infected Adults on Antiretroviral Therapy
Updated: 1/8/2018
A Phase II, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Evaluate the Safety, Tolerability, and Immunogenicity of ZOSTAVAX® (Zoster Vaccine Live) in Human Immunodeficiency Virus (HIV)-1-Infected Adults on Potent Combination ART With Conserved Immune Function
Status: Enrolling
Updated: 1/8/2018
Live Zoster Vaccine in HIV-Infected Adults on Antiretroviral Therapy
Updated: 1/8/2018
A Phase II, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Evaluate the Safety, Tolerability, and Immunogenicity of ZOSTAVAX® (Zoster Vaccine Live) in Human Immunodeficiency Virus (HIV)-1-Infected Adults on Potent Combination ART With Conserved Immune Function
Status: Enrolling
Updated: 1/8/2018
Click here to add this to my saved trials
Live Zoster Vaccine in HIV-Infected Adults on Antiretroviral Therapy
Updated: 1/8/2018
A Phase II, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Evaluate the Safety, Tolerability, and Immunogenicity of ZOSTAVAX® (Zoster Vaccine Live) in Human Immunodeficiency Virus (HIV)-1-Infected Adults on Potent Combination ART With Conserved Immune Function
Status: Enrolling
Updated: 1/8/2018
Live Zoster Vaccine in HIV-Infected Adults on Antiretroviral Therapy
Updated: 1/8/2018
A Phase II, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Evaluate the Safety, Tolerability, and Immunogenicity of ZOSTAVAX® (Zoster Vaccine Live) in Human Immunodeficiency Virus (HIV)-1-Infected Adults on Potent Combination ART With Conserved Immune Function
Status: Enrolling
Updated: 1/8/2018
Click here to add this to my saved trials
Live Zoster Vaccine in HIV-Infected Adults on Antiretroviral Therapy
Updated: 1/8/2018
A Phase II, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Evaluate the Safety, Tolerability, and Immunogenicity of ZOSTAVAX® (Zoster Vaccine Live) in Human Immunodeficiency Virus (HIV)-1-Infected Adults on Potent Combination ART With Conserved Immune Function
Status: Enrolling
Updated: 1/8/2018
Live Zoster Vaccine in HIV-Infected Adults on Antiretroviral Therapy
Updated: 1/8/2018
A Phase II, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Evaluate the Safety, Tolerability, and Immunogenicity of ZOSTAVAX® (Zoster Vaccine Live) in Human Immunodeficiency Virus (HIV)-1-Infected Adults on Potent Combination ART With Conserved Immune Function
Status: Enrolling
Updated: 1/8/2018
Click here to add this to my saved trials
Live Zoster Vaccine in HIV-Infected Adults on Antiretroviral Therapy
Updated: 1/8/2018
A Phase II, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Evaluate the Safety, Tolerability, and Immunogenicity of ZOSTAVAX® (Zoster Vaccine Live) in Human Immunodeficiency Virus (HIV)-1-Infected Adults on Potent Combination ART With Conserved Immune Function
Status: Enrolling
Updated: 1/8/2018
Live Zoster Vaccine in HIV-Infected Adults on Antiretroviral Therapy
Updated: 1/8/2018
A Phase II, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Evaluate the Safety, Tolerability, and Immunogenicity of ZOSTAVAX® (Zoster Vaccine Live) in Human Immunodeficiency Virus (HIV)-1-Infected Adults on Potent Combination ART With Conserved Immune Function
Status: Enrolling
Updated: 1/8/2018
Click here to add this to my saved trials
Live Zoster Vaccine in HIV-Infected Adults on Antiretroviral Therapy
Updated: 1/8/2018
A Phase II, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Evaluate the Safety, Tolerability, and Immunogenicity of ZOSTAVAX® (Zoster Vaccine Live) in Human Immunodeficiency Virus (HIV)-1-Infected Adults on Potent Combination ART With Conserved Immune Function
Status: Enrolling
Updated: 1/8/2018
Live Zoster Vaccine in HIV-Infected Adults on Antiretroviral Therapy
Updated: 1/8/2018
A Phase II, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Evaluate the Safety, Tolerability, and Immunogenicity of ZOSTAVAX® (Zoster Vaccine Live) in Human Immunodeficiency Virus (HIV)-1-Infected Adults on Potent Combination ART With Conserved Immune Function
Status: Enrolling
Updated: 1/8/2018
Click here to add this to my saved trials
Live Zoster Vaccine in HIV-Infected Adults on Antiretroviral Therapy
Updated: 1/8/2018
A Phase II, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Evaluate the Safety, Tolerability, and Immunogenicity of ZOSTAVAX® (Zoster Vaccine Live) in Human Immunodeficiency Virus (HIV)-1-Infected Adults on Potent Combination ART With Conserved Immune Function
Status: Enrolling
Updated: 1/8/2018
Live Zoster Vaccine in HIV-Infected Adults on Antiretroviral Therapy
Updated: 1/8/2018
A Phase II, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Evaluate the Safety, Tolerability, and Immunogenicity of ZOSTAVAX® (Zoster Vaccine Live) in Human Immunodeficiency Virus (HIV)-1-Infected Adults on Potent Combination ART With Conserved Immune Function
Status: Enrolling
Updated: 1/8/2018
Click here to add this to my saved trials
Live Zoster Vaccine in HIV-Infected Adults on Antiretroviral Therapy
Updated: 1/8/2018
A Phase II, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Evaluate the Safety, Tolerability, and Immunogenicity of ZOSTAVAX® (Zoster Vaccine Live) in Human Immunodeficiency Virus (HIV)-1-Infected Adults on Potent Combination ART With Conserved Immune Function
Status: Enrolling
Updated: 1/8/2018
Live Zoster Vaccine in HIV-Infected Adults on Antiretroviral Therapy
Updated: 1/8/2018
A Phase II, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Evaluate the Safety, Tolerability, and Immunogenicity of ZOSTAVAX® (Zoster Vaccine Live) in Human Immunodeficiency Virus (HIV)-1-Infected Adults on Potent Combination ART With Conserved Immune Function
Status: Enrolling
Updated: 1/8/2018
Click here to add this to my saved trials
Live Zoster Vaccine in HIV-Infected Adults on Antiretroviral Therapy
Updated: 1/8/2018
A Phase II, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Evaluate the Safety, Tolerability, and Immunogenicity of ZOSTAVAX® (Zoster Vaccine Live) in Human Immunodeficiency Virus (HIV)-1-Infected Adults on Potent Combination ART With Conserved Immune Function
Status: Enrolling
Updated: 1/8/2018
Live Zoster Vaccine in HIV-Infected Adults on Antiretroviral Therapy
Updated: 1/8/2018
A Phase II, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Evaluate the Safety, Tolerability, and Immunogenicity of ZOSTAVAX® (Zoster Vaccine Live) in Human Immunodeficiency Virus (HIV)-1-Infected Adults on Potent Combination ART With Conserved Immune Function
Status: Enrolling
Updated: 1/8/2018
Click here to add this to my saved trials
Live Zoster Vaccine in HIV-Infected Adults on Antiretroviral Therapy
Updated: 1/8/2018
A Phase II, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Evaluate the Safety, Tolerability, and Immunogenicity of ZOSTAVAX® (Zoster Vaccine Live) in Human Immunodeficiency Virus (HIV)-1-Infected Adults on Potent Combination ART With Conserved Immune Function
Status: Enrolling
Updated: 1/8/2018
Live Zoster Vaccine in HIV-Infected Adults on Antiretroviral Therapy
Updated: 1/8/2018
A Phase II, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Evaluate the Safety, Tolerability, and Immunogenicity of ZOSTAVAX® (Zoster Vaccine Live) in Human Immunodeficiency Virus (HIV)-1-Infected Adults on Potent Combination ART With Conserved Immune Function
Status: Enrolling
Updated: 1/8/2018
Click here to add this to my saved trials
Live Zoster Vaccine in HIV-Infected Adults on Antiretroviral Therapy
Updated: 1/8/2018
A Phase II, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Evaluate the Safety, Tolerability, and Immunogenicity of ZOSTAVAX® (Zoster Vaccine Live) in Human Immunodeficiency Virus (HIV)-1-Infected Adults on Potent Combination ART With Conserved Immune Function
Status: Enrolling
Updated: 1/8/2018
Live Zoster Vaccine in HIV-Infected Adults on Antiretroviral Therapy
Updated: 1/8/2018
A Phase II, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Evaluate the Safety, Tolerability, and Immunogenicity of ZOSTAVAX® (Zoster Vaccine Live) in Human Immunodeficiency Virus (HIV)-1-Infected Adults on Potent Combination ART With Conserved Immune Function
Status: Enrolling
Updated: 1/8/2018
Click here to add this to my saved trials
Live Zoster Vaccine in HIV-Infected Adults on Antiretroviral Therapy
Updated: 1/8/2018
A Phase II, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Evaluate the Safety, Tolerability, and Immunogenicity of ZOSTAVAX® (Zoster Vaccine Live) in Human Immunodeficiency Virus (HIV)-1-Infected Adults on Potent Combination ART With Conserved Immune Function
Status: Enrolling
Updated: 1/8/2018
Live Zoster Vaccine in HIV-Infected Adults on Antiretroviral Therapy
Updated: 1/8/2018
A Phase II, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Evaluate the Safety, Tolerability, and Immunogenicity of ZOSTAVAX® (Zoster Vaccine Live) in Human Immunodeficiency Virus (HIV)-1-Infected Adults on Potent Combination ART With Conserved Immune Function
Status: Enrolling
Updated: 1/8/2018
Click here to add this to my saved trials
Live Zoster Vaccine in HIV-Infected Adults on Antiretroviral Therapy
Updated: 1/8/2018
A Phase II, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Evaluate the Safety, Tolerability, and Immunogenicity of ZOSTAVAX® (Zoster Vaccine Live) in Human Immunodeficiency Virus (HIV)-1-Infected Adults on Potent Combination ART With Conserved Immune Function
Status: Enrolling
Updated: 1/8/2018
Live Zoster Vaccine in HIV-Infected Adults on Antiretroviral Therapy
Updated: 1/8/2018
A Phase II, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Evaluate the Safety, Tolerability, and Immunogenicity of ZOSTAVAX® (Zoster Vaccine Live) in Human Immunodeficiency Virus (HIV)-1-Infected Adults on Potent Combination ART With Conserved Immune Function
Status: Enrolling
Updated: 1/8/2018
Click here to add this to my saved trials
Live Zoster Vaccine in HIV-Infected Adults on Antiretroviral Therapy
Updated: 1/8/2018
A Phase II, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Evaluate the Safety, Tolerability, and Immunogenicity of ZOSTAVAX® (Zoster Vaccine Live) in Human Immunodeficiency Virus (HIV)-1-Infected Adults on Potent Combination ART With Conserved Immune Function
Status: Enrolling
Updated: 1/8/2018
Live Zoster Vaccine in HIV-Infected Adults on Antiretroviral Therapy
Updated: 1/8/2018
A Phase II, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Evaluate the Safety, Tolerability, and Immunogenicity of ZOSTAVAX® (Zoster Vaccine Live) in Human Immunodeficiency Virus (HIV)-1-Infected Adults on Potent Combination ART With Conserved Immune Function
Status: Enrolling
Updated: 1/8/2018
Click here to add this to my saved trials
Live Zoster Vaccine in HIV-Infected Adults on Antiretroviral Therapy
Updated: 1/8/2018
A Phase II, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Evaluate the Safety, Tolerability, and Immunogenicity of ZOSTAVAX® (Zoster Vaccine Live) in Human Immunodeficiency Virus (HIV)-1-Infected Adults on Potent Combination ART With Conserved Immune Function
Status: Enrolling
Updated: 1/8/2018
Live Zoster Vaccine in HIV-Infected Adults on Antiretroviral Therapy
Updated: 1/8/2018
A Phase II, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Evaluate the Safety, Tolerability, and Immunogenicity of ZOSTAVAX® (Zoster Vaccine Live) in Human Immunodeficiency Virus (HIV)-1-Infected Adults on Potent Combination ART With Conserved Immune Function
Status: Enrolling
Updated: 1/8/2018
Click here to add this to my saved trials
Live Zoster Vaccine in HIV-Infected Adults on Antiretroviral Therapy
Updated: 1/8/2018
A Phase II, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Evaluate the Safety, Tolerability, and Immunogenicity of ZOSTAVAX® (Zoster Vaccine Live) in Human Immunodeficiency Virus (HIV)-1-Infected Adults on Potent Combination ART With Conserved Immune Function
Status: Enrolling
Updated: 1/8/2018
Live Zoster Vaccine in HIV-Infected Adults on Antiretroviral Therapy
Updated: 1/8/2018
A Phase II, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Evaluate the Safety, Tolerability, and Immunogenicity of ZOSTAVAX® (Zoster Vaccine Live) in Human Immunodeficiency Virus (HIV)-1-Infected Adults on Potent Combination ART With Conserved Immune Function
Status: Enrolling
Updated: 1/8/2018
Click here to add this to my saved trials
Live Zoster Vaccine in HIV-Infected Adults on Antiretroviral Therapy
Updated: 1/8/2018
A Phase II, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Evaluate the Safety, Tolerability, and Immunogenicity of ZOSTAVAX® (Zoster Vaccine Live) in Human Immunodeficiency Virus (HIV)-1-Infected Adults on Potent Combination ART With Conserved Immune Function
Status: Enrolling
Updated: 1/8/2018
Live Zoster Vaccine in HIV-Infected Adults on Antiretroviral Therapy
Updated: 1/8/2018
A Phase II, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Evaluate the Safety, Tolerability, and Immunogenicity of ZOSTAVAX® (Zoster Vaccine Live) in Human Immunodeficiency Virus (HIV)-1-Infected Adults on Potent Combination ART With Conserved Immune Function
Status: Enrolling
Updated: 1/8/2018
Click here to add this to my saved trials
Live Zoster Vaccine in HIV-Infected Adults on Antiretroviral Therapy
Updated: 1/8/2018
A Phase II, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Evaluate the Safety, Tolerability, and Immunogenicity of ZOSTAVAX® (Zoster Vaccine Live) in Human Immunodeficiency Virus (HIV)-1-Infected Adults on Potent Combination ART With Conserved Immune Function
Status: Enrolling
Updated: 1/8/2018
Live Zoster Vaccine in HIV-Infected Adults on Antiretroviral Therapy
Updated: 1/8/2018
A Phase II, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Evaluate the Safety, Tolerability, and Immunogenicity of ZOSTAVAX® (Zoster Vaccine Live) in Human Immunodeficiency Virus (HIV)-1-Infected Adults on Potent Combination ART With Conserved Immune Function
Status: Enrolling
Updated: 1/8/2018
Click here to add this to my saved trials
Live Zoster Vaccine in HIV-Infected Adults on Antiretroviral Therapy
Updated: 1/8/2018
A Phase II, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Evaluate the Safety, Tolerability, and Immunogenicity of ZOSTAVAX® (Zoster Vaccine Live) in Human Immunodeficiency Virus (HIV)-1-Infected Adults on Potent Combination ART With Conserved Immune Function
Status: Enrolling
Updated: 1/8/2018
Live Zoster Vaccine in HIV-Infected Adults on Antiretroviral Therapy
Updated: 1/8/2018
A Phase II, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Evaluate the Safety, Tolerability, and Immunogenicity of ZOSTAVAX® (Zoster Vaccine Live) in Human Immunodeficiency Virus (HIV)-1-Infected Adults on Potent Combination ART With Conserved Immune Function
Status: Enrolling
Updated: 1/8/2018
Click here to add this to my saved trials
Live Zoster Vaccine in HIV-Infected Adults on Antiretroviral Therapy
Updated: 1/8/2018
A Phase II, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Evaluate the Safety, Tolerability, and Immunogenicity of ZOSTAVAX® (Zoster Vaccine Live) in Human Immunodeficiency Virus (HIV)-1-Infected Adults on Potent Combination ART With Conserved Immune Function
Status: Enrolling
Updated: 1/8/2018
Live Zoster Vaccine in HIV-Infected Adults on Antiretroviral Therapy
Updated: 1/8/2018
A Phase II, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Evaluate the Safety, Tolerability, and Immunogenicity of ZOSTAVAX® (Zoster Vaccine Live) in Human Immunodeficiency Virus (HIV)-1-Infected Adults on Potent Combination ART With Conserved Immune Function
Status: Enrolling
Updated: 1/8/2018
Click here to add this to my saved trials
Live Zoster Vaccine in HIV-Infected Adults on Antiretroviral Therapy
Updated: 1/8/2018
A Phase II, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Evaluate the Safety, Tolerability, and Immunogenicity of ZOSTAVAX® (Zoster Vaccine Live) in Human Immunodeficiency Virus (HIV)-1-Infected Adults on Potent Combination ART With Conserved Immune Function
Status: Enrolling
Updated: 1/8/2018
Live Zoster Vaccine in HIV-Infected Adults on Antiretroviral Therapy
Updated: 1/8/2018
A Phase II, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Evaluate the Safety, Tolerability, and Immunogenicity of ZOSTAVAX® (Zoster Vaccine Live) in Human Immunodeficiency Virus (HIV)-1-Infected Adults on Potent Combination ART With Conserved Immune Function
Status: Enrolling
Updated: 1/8/2018
Click here to add this to my saved trials
Bioequivalency Study of Valacyclovir Hydrochloride 1000 mg Under Fed Conditions
Updated: 1/19/2018
A Single Dose, 2-Period, 2-Treatment 2-Way Crossover Bioequivalency Study of Valacyclovir Caplets Under Fed Conditions
Status: Enrolling
Updated: 1/19/2018
Bioequivalency Study of Valacyclovir Hydrochloride 1000 mg Under Fed Conditions
Updated: 1/19/2018
A Single Dose, 2-Period, 2-Treatment 2-Way Crossover Bioequivalency Study of Valacyclovir Caplets Under Fed Conditions
Status: Enrolling
Updated: 1/19/2018
Click here to add this to my saved trials
Bioequivalency Study of Valacyclovir Hydrochloride 1000 mg Under Fasting Conditions
Updated: 1/19/2018
A Single Dose, 2-Period, 2-Treatment 2-Way Crossover Bioequivalency Study of Valacyclovir Caplets Under Fasting Conditions
Status: Enrolling
Updated: 1/19/2018
Bioequivalency Study of Valacyclovir Hydrochloride 1000 mg Under Fasting Conditions
Updated: 1/19/2018
A Single Dose, 2-Period, 2-Treatment 2-Way Crossover Bioequivalency Study of Valacyclovir Caplets Under Fasting Conditions
Status: Enrolling
Updated: 1/19/2018
Click here to add this to my saved trials